The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
Abstract
BACKGROUND: We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with advanced chronic heart failure and intraventricular conduction delays. METHODS: A total of 1520 patients who had advanced heart failure (New York Heart Association class III or IV) due to ischemic or nonischemic cardiomyopathies and a QRS interval of at least 120 msec were randomly assigned in a 1:2:2 ratio to receive optimal pharmacologic therapy (diuretics, angiotensin-converting-enzyme inhibitors, beta-blockers, and spironolactone) alone or in combination with cardiac-resynchronization therapy with either a pacemaker or a pacemaker-defibrillator. The primary composite end point was the time to death from or hospitalization for any cause. RESULTS: As compared with optimal pharmacologic therapy alone, cardiac-resynchronization therapy with a pacemaker decreased the risk of the primary end point (hazard ratio, 0.81; P=0.014), as did cardiac-resynchronization therapy with a pacemaker-defibrillator (hazard ratio, 0.80; P=0.01). The risk of the combined end point of death from or hospitalization for heart failure was reduced by 34 percent in the pacemaker group (P<0.002) and by 40 percent in the pacemaker-defibrillator group (P<0.001 for the comparison with the pharmacologic-therapy group). A pacemaker reduced the risk of the secondary end point of death from any cause by 24 percent (P=0.059), and a pacemaker-defibrillator reduced the risk by 36 percent (P=0.003). CONCLUSIONS: In patients with advanced heart failure and a prolonged QRS interval, cardiac-resynchronization therapy decreases the combined risk of death from any cause or first hospitalization and, when combined with an implantable defibrillator, significantly reduces mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While clinical improvements are generally achieved, six-month nonresponder rates have been reported to be as high as 32–43%11,13, which is partially attributed to anatomic constraints of lead positioning14.”
From Synchronized Biventricular Heart Pacing in a Closed-chest Porcine Model based on Wirelessly Powered Leadless Pacemakers (2020) · cites this paper as [13]
In the citing paper
“Device therapies (implantable cardioverter defibrillator [ICD], cardiac resynchronization therapy [CRT], and CRT with an implantable defibrillator [CRT-D]) have similar efficacies and risks in patients with HFrEF with or without diabetes.[522][523][524][525]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [524]
Citations
Cites
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Cardiac Resynchronization in Chronic Heart Failure
Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013168 · Cited by 4,648
CARDIAC RESYNCHRONIZATION IN CHRONIC HEART FAILURE
Braham, W. I. T. A., Isher, W. E. G. F., Mith, L. S., Elurgio, D. A. B. D., Eon, A. N. R. L., Oh, E., Ocovic, D. U. Z. K., Acker, M. G., Lavell, L. C., Ayes, D. A. L. H., et al. (2002) · Cited by 3,808
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Self-citationDiscrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Self-citationSt John Sutton, M. G., Plappert, T., Abraham, W. T., Smith, A. L., DeLurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Fisher, W. G., Ellestad, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000065226.24159.e9 · Cited by 1,124
Auricchio, A., Stellbrink, C., Sack, S., Block, M., Vogt, J. Ü., Bakker, P., Huth, C., Schöndube, F., Wolfhard, U., Böcker, D., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01895-8 · Cited by 1,026
Linde, C., Leclercq, C., Rex, S., Garrigue, S., Lavergne, T., Cazeau, S., McKenna, W., Fitzgerald, M., Deharo, J.-C., Alonso, C., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01932-0 · Cited by 973
Baldasseroni, S., Opasich, C., Gorini, M., Lucci, D., Marchionni, N., Marini, M., Campana, C., Perini, G., Deorsola, A., Masotti, G., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.121264 · Cited by 800
Cited by
Items 601–700 of 1,014
Witte, K. K., Pipes, R. R., Nanthakumar, K., & Parker, J. D. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.12.003 · Cited by 84
Parkash, R., Stevenson, W. G., Epstein, L. M., & Maisel, W. H. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.009 · Cited by 81
Influence of left bundle branch block on long-term mortality in a population with heart failure
Tabrizi, F. N., Englund, A., Rosenqvist, M., Wallentin, L. C., & Stenestrand, U. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm262 · Cited by 82
More Favorable Response to Cardiac Resynchronization Therapy in Women Than in Men
Cheng, Y., Zhang, J., Li, W., Lin, X., Zeng, W., Tang, K., Tang, A., He, J., Xu, Q., Mei, M.-Y., et al. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001786 · Cited by 83
Baseline Characteristics of Patients Recruited Into the CARE-HF Study
Cleland, J. G. F., Daubert, J., Erdmann, E., Freemantle, N., Gras, D., KAPPENBERGER, L. J., Klein, W. W., & Tavazzi, L. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.010 · Cited by 81
Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy
Maisch, B., & Pankuweit, S. (2012) · Herz · doi:10.1007/s00059-012-3679-9 · Cited by 86
Gasparini, M., Steinberg, J. S., Arshad, A., Regoli, F. D., Galimberti, P., Rosier, A., Daubert, J., Klersy, C., Kamath, G., & Leclercq, C. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp572 · Cited by 80
“Cardiac resynchronization therapy has been increasingly employed to treat advanced HF patients who have EF 35% and QRS 120 ms.(3,10) In particular, in patients with HF, CRT may improve LV haemodynamics, while maintenance of SR may be favoured from the resulting improvement in the atrial haemodynamic milieu.”
MethodD’Ascia, C., Cittadini, A., Monti, M. G., Riccio, G., & Saccà, L. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi579 · Cited by 81
Goda, A., Lund, L. H., & MANCINI, D. M. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.09.007 · Cited by 80
Curtis, A. B., Ellenbogen, K. A., Hammill, S. C., Hayes, D. L., REYNOLDS, D. W., Wilber, D. J., & CAIN, M. E. (2004) · Heart Rhythm · doi:10.1016/j.hrthm.2004.08.003 · Cited by 79
Pedersen, S. S., Theuns, D. A. M. J., Muskens, A. J. Q. M., Erdman, R. A. M., & Jordaens, L. J. L. M. (2007) · EP Europace · doi:10.1093/europace/eum041 · Cited by 90
Steffel, J., Robertson, M., Singh, J. P., Abraham, W. T., Bax, J. J., BORER, J. S., Dickstein, K., Ford, I., Gorcsan, J., Gras, D., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv242 · Cited by 80
Conraads, V. M., Vanderheyden, M., Paelinck, B. P., Verstreken, S., Blankoff, I., Miljoen, H., SUTTER, J. D., & Beckers, P. J. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32801164b3 · Cited by 80
Not Everyone With an Ejection Fraction ≤30% Should Receive an ICD
Buxton, A. E. (2005) · Circulation · doi:10.1161/01.cir.0000165057.88551.2c · Cited by 80
Cardiac device infections are associated with a significant mortality risk
de Bie, M. K., van Rees, J. B., Thijssen, J., Borleffs, C. J. W., Trines, S. A. I. P., Cannegieter, S. C., Schalij, M. J., & van Erven, L. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.10.034 · Cited by 82
Dyssynchrony and the Risk of Ventricular Arrhythmias
Kutyifa, V., Pouleur, A., Knappe, D., Al‐Ahmad, A., Gibiński, M., Wang, P. J., McNitt, S. A., Merkely, B. P., Goldenberg, I., Solomon, S. D., et al. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.12.008 · Cited by 79
“11 (11) 21 (22) 85 (30) 70 49 4 17 98 57 21 (75) 10 (86) 30 (251) 15 (81) 6 (90) 22 (259) 8 (88) 4 (92) 9 (272) 31 (32) 37 (39) 148 (53) 65 (68) 59 (61) 133 (47) 54 (56) 72 (75) 212 (75) 13 (14) 9 (9) 25 (9) 29 (30) 15 (16) 43 (15) 34 (35) 33 (34) 56 (20) 38 (40) 27 (28) 68 (24) 55 (58) 48 (50) 102 (37) 15 (16) 9 (10)…”
Heart failure in African Americans: Disparities can be overcome
Sharma, A. K., Colvin, M. M., & Yancy, C. W. (2014) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.81a.13045 · Cited by 95
Kandala, J., Upadhyay, G. A., Altman, R., Parks, K. A., Orencole, M. P., Mela, T., Heist, E. K., & Singh, J. P. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht123 · Cited by 79
Zanon, F., Marcantoni, L., Baracca, E., Pastore, G., Lanza, D., Fraccaro, C., Picariello, C., Conte, L., Aggio, S., Roncon, L., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.05.015 · Cited by 79
Cardiac Resynchronization Therapy in Patients With Minimal Heart Failure
Adabağ, S., Roukoz, H., Anand, I. S., & Moss, A. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.022 · Cited by 80
“Finally, in large clinical trials, utilization of CRT and ICD in addition to optimal medical therapy has resulted in a 39% reduction in HF hospitalization and a 36% reduction in mortality in comparison with ICD alone (8,9).”
Cardiac Implantable Electronic Devices
Al‐Khatib, S. M. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2308353 · Cited by 88
First Human Demonstration of Cardiac Stimulation With Transcutaneous Ultrasound Energy Delivery
Lee, K. L., Lau, C., Tse, H., Echt, D. S., Heaven, D., Smith, W., & Hood, M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.081 · Cited by 79
Olshansky, B., Day, J. D., Sullivan, R. M., Yong, P., Galle, E. G., & Steinberg, J. S. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.07.038 · Cited by 78
Onishi, T., Onishi, T., Marek, J. J., Ahmed, M., Haberman, S. C., Oyenuga, O. A., ADELSTEIN, E. C., SCHWARTZMAN, D. S., Saba, S., & Gorcsan, J. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000112 · Cited by 80
Peinado, R., Torrecilla, E. G., Ormaetxe, J. M., Álvarez, M., León, R. C., & Alzueta, J. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73128-8 · Cited by 80
Procedural Success of Left Ventricular Lead Placement for Cardiac Resynchronization Therapy
Gamble, J. H. P., Herring, N., Ginks, M., Rajappan, K., Bashir, Y., & Betts, T. R. (2015) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2015.08.009 · Cited by 81
Impact of pacing on systemic ventricular function in L-transposition of the great arteries
Hofferberth, S. C., Alexander, M. E., Mah, D. Y., Bautista‐Hernández, V., del Nido, P. J., & Fynn‐Thompson, F. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.08.064 · Cited by 78
The Valsalva Maneuver: A Bedside “Biomarker” for Heart Failure
Felker, G. M., Cuculich, P. S., & Gheorghiade, M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.059 · Cited by 77
Albertsen, A. E., Nielsen, J. C., Pedersen, A. K., HANSEN, P. S., Jensen, H. K., & Mortensen, P. T. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.40066.x · Cited by 76
Clinical Management and Prevention of Sudden Cardiac Death
Yousuf, O. K., Chrispin, J., Tomaselli, G. F., & Berger, R. D. (2015) · Circulation Research · doi:10.1161/circresaha.116.304555 · Cited by 92
Mazurek, J. A., & Jessup, M. L. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.08.001 · Cited by 81
Kramer, D. B., Kesselheim, A. S., Brock, D. W., & Maisel, W. H. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.07.018 · Cited by 77
Noninvasive Imaging in Cardiac Resynchronization Therapy—Part 1: Selection of Patients
Ypenburg, C., Westenberg, J. J. M., Bleeker, G. B., de Veire, N. V., Marsan, N. A., Henneman, M. M., van der Wall, E. E., Schalij, M. J., Abraham, T. P., Barold, S. S., et al. (2008) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.01212.x · Cited by 77
“Patients with HF can exhibit dyssynchrony at different levels, which can be (partially) corrected by CRT8: (1) Interatrial dyssynchrony, reflecting dyssynchronous contraction between the right and left atrium,9 (2) Atrioventricular (AV) dyssynchrony, resulting in reduced LV filling time, (3) Interventricular dyssynchr…”
BackgroundProvidencia, R. A., Kramer, D. B., Pimenta, D., Babu, G. G., Hatfield, L. A., Ioannou, A., Novak, J., Hauser, R. G., & Lambiase, P. D. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002418 · Cited by 77
What Is the Heart? Anatomy, Function, Pathophysiology, and Misconceptions
Buckberg, G. D., Nanda, N. C., Nguyen, C. T., & Kočica, M. J. (2018) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd5020033 · Cited by 124
“‘Resynchronization’ is achieved by simultaneously pacing the LV and RV with the aim of restoring ‘synchrony’, but its portended treatment goals are only sometimes met [84].”
BackgroundSkali, H., Dwyer, E. M., Goldstein, R., Haigney, M., Krone, R., Kukin, M., Lichstein, E., McNitt, S., Moss, A. J., Pfeffer, M. A., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.71 · Cited by 76
Taylor, R. J., Umar, F., Panting, J. R., Stegemann, B., & Leyva, F. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.10.024 · Cited by 77
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure
Kim, M., Lee, J., Kim, E. J., Park, D.-G., Park, S., Park, J. J., Shin, M., Yoo, B., Youn, J., Lee, S. E., et al. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0009 · Cited by 80
Indications for Cardiac Resynchronization Therapy
Normand, C., Linde, C. M., Singh, J. P., & Dickstein, K. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2018.01.022 · Cited by 80
Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines
Lebedev, D. S., Mikhaylov, E. N., Neminuschiy, N. M., Golukhova, E. Z., Babokin, V. E., Bereznitskaya, V. V., Vasichkina, E. S., Garkina, S. V., Sp, G., Davtyan, K. V., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4600 · Cited by 95
Trimble, M. A., Borges‐Neto, S., Honeycutt, E. F., Shaw, L. K., Pagnanelli, R., Chen, J., Iskandrian, A. E., Garcia, E. V., & Velazquez, E. J. (2008) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2008.06.007 · Cited by 76
“Several studies have shown improvements in quality of life, functional class, exercise capacity, and ejection fraction for patients who received CRT in addition to optimal medical therapy.4-7 Two recent studies have documented that CRT provides benefits beyond symptomatic improvement and have shown mortality benefits…”
InfluentialAlbertsen, A. E., Nielsen, J. C., Poulsen, S. H., Mortensen, P. T., Pedersen, A. K., HANSEN, P. S., Jensen, H. K., & Egeblad, H. (2008) · EP Europace · doi:10.1093/europace/eun023 · Cited by 83
“Implantation of BiV-pacing systems may be difficult in some patients and often time-consuming as indicated by surgery times of 162 and 164 min, respectively, in the MIRACLE and COMPANION trials.(13,28) However, the present study demonstrated that successful implantation of BiVpacing systems can be done with considerab…”
ResultGinks, M., Shetty, A., Lambiase, P. D., Duckett, S. G., Bostock, J., Peacock, J. L., Rhode, K., Bucknall, C. A., Gill, J. S., Taggart, P. I., et al. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.967505 · Cited by 76
Electrical Signals Applied During the Absolute Refractory Period
Lawo, T., Borggrefe, M., Butter, C., Hindricks, G., Schmidinger, H., Mika, Y., Burkhoff, D., Pappone, C., & Sabbah, H. N. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.093 · Cited by 75
How robust are clinical trials in heart failure?
Docherty, K. F., Campbell, R. T., Jhund, P. S., Petrie, M. C., & McMurray, J. J. V. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw427 · Cited by 83
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure
Heidenreich, P. A., Fonarow, G. C., Breathett, K. K., Jurgens, C. Y., Pisani, B., Pozehl, B., Spertus, J. A., Taylor, K. G., Thibodeau, J. T., Yancy, C. W., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.07.023 · Cited by 86
Goldstein, N. E., & Lynn, J. (2006) · Perspectives in biology and medicine · doi:10.1353/pbm.2006.0008 · Cited by 76
Epstein, A. E., Baessler, C. A., Curtis, A. B., Estes, N. A. M., Gersh, B. J., Grubb, B. P., & Mitchell, L. B. (2007) · Circulation · doi:10.1161/circulationaha.106.180203 · Cited by 78
Perini, A. P., Bartolini, S., Pieragnoli, P., Ricciardi, W., Perrotta, L., Valleggi, A., Vergaro, G., Michelotti, F., Boggian, G., Sassone, B., et al. (2013) · EP Europace · doi:10.1093/europace/eut190 · Cited by 79
Women have better long-term prognosis than men after cardiac resynchronization therapy
Zabarovskaja, S., Gadler, F., Braunschweig, F., Ståhlberg, M., Hörnsten, J., Linde, C. M., & Lund, L. H. (2012) · EP Europace · doi:10.1093/europace/eus039 · Cited by 82
“Estimated 1-year survival in RCTs was 85–95% and estimated 1-year event-free survival was 56–95%.(1,2,6,7) In comparison, in our registry, at 1 year, overall survival was 91% and survival free from HF hospitalization was 57%.”
BackgroundPredictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study
Klein, G. G., Lissel, C., Fuchs, A.-C., Gardiwal, A., Oswald, H., deSousa, M., Pichlmaier, A. M., Lichtinghagen, R., Geerlings, H., Lippolt, P., et al. (2006) · EP Europace · doi:10.1093/europace/eul082 · Cited by 77
“This is in accordance with data showing that heart failure patients with prolonged QRS-duration have higher mortality, show a significant benefit from ICD therapy, and have more recurrences of fast VTs.4,28,29 Our study does not permit the drawing of any conclusions on the role of CRT–ICDs on the incidence of VT/VF oc…”
ResultThe Impact of Cardiac Resynchronization Therapy on Obstructive Sleep Apnea in Heart Failure Patients
Stanchina, M. L., Ellison, K., Malhotra, A., Anderson, M. T., KIRK, M. M., Benser, M. E., Tosi, C., Carlisle, C. C., Millman, R. P., & Buxton, A. E. (2007) · CHEST Journal · doi:10.1378/chest.06-2509 · Cited by 74
Ruwald, A.-C., Kutyifa, V., Ruwald, M. H., Solomon, S., Daubert, J. P., Jons, C., Brenyo, A., McNitt, S., Do, D., Tanabe, K., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu294 · Cited by 74
Colquitt, J. L., Mendes, D., Clegg, A. J., Harris, P., Cooper, K., Picot, J., & Bryant, J. (2014) · Health Technology Assessment · doi:10.3310/hta18560 · Cited by 84
Loring, Z., Chelliah, S., Selvester, R. H. S., Wagner, G. S., & Strauss, D. G. (2011) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2011.06.008 · Cited by 74
Gorcsan, J., Anderson, C. P., Tayal, B., Sugahara, M., Walmsley, J., Starling, R. C., & Lumens, J. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.07.013 · Cited by 75
Rickard, J., Popović, Z., Verhaert, D., Sraow, D. I., Baranowski, B. J., Martin, D. O., Lindsay, B. D., Varma, N., TCHOU, P. J., Grimm, R. A., et al. (2011) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.03022.x · Cited by 77
Analysis of ventricular function by CT
Rizvi, A., Deaño, R. C., Bachman, D. P., Xiong, G., Min, J. K., & Truong, Q. A. (2014) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2014.11.007 · Cited by 74
Rademakers, L. M., Kerckhoven, R. V., van Deursen, C. J. M., Strik, M., van Hunnik, A., Kuiper, M., Lampert, A., Klersy, C., Leyva, F., Auricchio, A., et al. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.931865 · Cited by 75
AlJaroudi, W., Hage, F. G., Hermann, D., Doppalapudi, H., Venkataraman, R., Heo, J., & Iskandrian, A. E. (2010) · Journal of Nuclear Cardiology · doi:10.1007/s12350-009-9169-7 · Cited by 74
Arbelo, E., Tolosana, J. M., Trucco, E., Penela, D., Borràs, R., Doltra, A., Andreu, D., Aceña, M., Berruezo, A., Sitges, M., et al. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12322 · Cited by 75
Leclercq, C., Sadoul, N., Mont, L., Defaye, P., Osca, J., Mouton, E., Isnard, R., Habib, G., Zamorano, J. L., Dérumeaux, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv422 · Cited by 80
Treatment strategies for the right heart in pulmonary hypertension
Westerhof, B. E., Saouti, N., van der Laarse, W. J., Westerhof, N., & Noordegraaf, A. V. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx148 · Cited by 80
van Bommel, R. J., Borleffs, C. J. W., Ypenburg, C., Marsan, N. A., Delgado, V., Bertini, M., van der Wall, E. E., Schalij, M. J., & Bax, J. J. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq252 · Cited by 72
“This is also true for trials that investigated the effect of CRT on morbidity and mortality.(8,9) Based on guidelines derived from these trials, it has been estimated that only 10% of heart failure patients meet the current criteria for CRT,(18) and a more recent study by McAlister et al.”
BackgroundGronda, E., Bourge, R. C., Costanzo, M. R., Deng, M. C.-H. K., MANCINI, D. M., Martinelli, L., & Torre‐Amione, G. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.06.005 · Cited by 72
“The Comparison of Medical Therapy, Pacing, and efibrillation in Heart Failure (COMPANION) trial was a arger study (N 1,520 patients), with a similar study opulation to that of the MIRACLE trial (except the QRS uration cut-off was 120 milliseconds), comparing ptimum medical therapy to CRT, or to CRT with an CD in a 1:2…”
MethodPacemaker and ICD leads: Strategies for long-term management
Borek, P., & Wilkoff, B. L. (2008) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9249-7 · Cited by 75
Lenarczyk, R., Kowalski, O., Kukulski, T., Pruszkowska‐Skrzep, P., Sokal, A., Szulik, M., Zielińska, T., Kowalczyk, J. P., Pluta, S., Średniawa, B., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.009 · Cited by 73
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
Cheitlin, M. D. (2010) · Yearbook of Cardiology · doi:10.1016/s0145-4145(10)79851-8 · Cited by 74
Bleeker, G. B., Bax, J. J., Paul Steendijk, A., Schalij, M. J., & van der Wall, E. E. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0505 · Cited by 74
Miller, W. L., Hartman, K. A., Grill, D. E., Struck, J., Bergmann, A., & Jaffe, A. S. (2011) · Heart · doi:10.1136/heartjnl-2011-300823 · Cited by 72
Onishi, T., Saha, S. K., Ludwig, D. R., Onishi, T., Marek, J. J., Cavalcante, J. L., Schelbert, E. B., SCHWARTZMAN, D. S., & Gorcsan, J. (2013) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-15-95 · Cited by 72
“Cardiac resynchronization therapy (CRT) has had a major impact on many heart failure patients with depressed ejection fraction conferring symptomatic relief and survival benefit [1-3].”
BackgroundUse of Patient-Reported Outcomes in Heart Failure: From Clinical Trials to Routine Practice
Savarese, G., Lindenfeld, J. M., Stolfo, D., Adams, K. F., Ahmad, T., Desai, N. R., Ammirati, E., Gottlieb, S. S., Psotka, M. A., Rosano, G. M. C., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2778 · Cited by 76
Lim, P., Donal, E., Lafitte, S., Dérumeaux, G., Habib, G., Réant, P., Thivolet, S., Lellouche, N., Grimm, R. A., & Guéret, P. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr073 · Cited by 76
Gatzoulis, K. A., Vouliotis, A.-I., Tsiachris, D., Σαλούρου, Μ., Archontakis, S., Dilaveris, P., Gialernios, T. P., Αρσένος, Π., Karystinos, G., Sideris, S. K., et al. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000216 · Cited by 71
Are complications of implantable defibrillators under-estimated and benefits over-estimated?
Brignole, M. (2009) · EP Europace · doi:10.1093/europace/eup174 · Cited by 69
Brachmann, J., Böhm, M., Rybak, K., Klein, G. G., Butter, C., Klemm, H. U., Schomburg, R., Siebermair, J., Israel, C. W., Sinha, A. M., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr045 · Cited by 80
Clark, A. L., Goode, K. M., & Cleland, J. G. F. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.05.001 · Cited by 72
“It has become particularly important to recognise conduction abnormalities in heart failure patients with the availability of biventricular pacing [7,8].”
BackgroundWhat is treatment success in cardiac resynchronization therapy?
Foley, P. W. X., Leyva, F., & Frenneaux, M. P. (2009) · EP Europace · doi:10.1093/europace/eup308 · Cited by 82
Timbie, J. W., Fox, D. S., Busum, K. R. V., & Schneider, E. C. (2012) · Health Affairs · doi:10.1377/hlthaff.2012.0150 · Cited by 70
Smith, T. W., Jordaens, L. J. L. M., Theuns, D., van Dessel, P. F. H. M., Wilde, A. A. M., & Hunink, M. G. M. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs090 · Cited by 78
Kück, K., Bordachar, P., Borggrefe, M., Boriani, G., Burri, H., Leyva, F., SCHAUERTE, P. N., Theuns, D. A. M. J., Thibault, B., Reviewers, D., et al. (2013) · EP Europace · doi:10.1093/europace/eut311 · Cited by 78
Groh, W. J., Bhakta, D., Tomaselli, G. F., Aleong, R. G., Teixeira, R. A., Amato, A. A., Asirvatham, S. J., Cha, Y., Corrado, D., Duboc, D., et al. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.04.022 · Cited by 78
Clinical Effects of Cardiac Contractility Modulation (CCM) as a Treatment for Chronic Heart Failure
Borggrefe, M., & Burkhoff, D. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs078 · Cited by 71
“Cardiac resynchronization therapy (CRT) improves symptoms, quality of life, and exercise tolerance, and reduces hospitalizations in patients with advanced heart failure and increased QRS duration.(1,2) The results of a recent study showed that patients with mechanical dyssynchrony detected by tissue Doppler imaging bu…”
BackgroundSantini, M., Ricci, R. P., Lunati, M., Landolina, M., Perego, G. B., Marzegalli, M., Schirru, M., Belvito, C., Brambilla, R., Guenzati, G., et al. (2008) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9321-3 · Cited by 68
Buxton, M. J., Caine, N., Chase, D. P., Connelly, D. T., Grace, A. A., Jackson, C. H., Parkes, J., & Sharples, L. D. (2006) · Health Technology Assessment · doi:10.3310/hta10270 · Cited by 84
Roque, C., Trevisi, N. M., Silberbauer, J., Olóriz, T., Mizuno, H., Baratto, F., Bisceglia, C., Sora, N., Marzi, A., Radinovic, A., et al. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001796 · Cited by 71
His Bundle Pacing: A New Strategy for Physiological Ventricular Activation
Lewis, A., Foley, P. W. X., Whinnett, Z. I., Keene, D., & Chandrasekaran, B. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010972 · Cited by 78
“In patients with impairment of left ventricular (LV) systolic function and dyssynchrony attributable to left bundle branch block with a broad QRS duration, the benefits of at least partial restoration of ventricular synchrony with cardiac resynchronization therapy (CRT) from RV and coronary venous approaches are well…”
BackgroundImplications of Left Bundle Branch Block in Patient Treatment
Kumar, V., Venkataraman, R., AlJaroudi, W., Osorio, J., Heo, J., Iskandrian, A. E., & Hage, F. G. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.09.029 · Cited by 70
Heart failure as a substrate and trigger for ventricular tachycardia
Alvarez, C., Cronin, E. M., Baker, W. L., & Kluger, J. (2019) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-019-00623-x · Cited by 74
Disparities in Access to Left Ventricular Assist Device Therapy
Joyce, D. L., Conte, J. V., Russell, S. D., Joyce, L. D., & Chang, D. C. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.02.065 · Cited by 70
Al‐Khatib, S. M., Sanders, G. D., Mark, D. B., Lee, K. L., Bardy, G. H., Bigger, J. T., Buxton, A. E., Connolly, S. J., Kadish, A. H., Moss, A. J., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.005 · Cited by 73
Self-citationWokhlu, A., Rea, R. F., Asirvatham, S. J., Webster, T. L., Brooke, K. L., Hodge, D. O., Wiste, H. J., Dong, Y.-X., Hayes, D. L., & Cha, Y. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.07.009 · Cited by 77
Foley, P. W. X., Muhyaldeen, S., Chalil, S., Smith, R. E. A., Sanderson, J. E., & Leyva, F. (2008) · EP Europace · doi:10.1093/europace/eup037 · Cited by 76
Linde, C. M., Mealing, S., Hawkins, N., Eaton, J., Brown, B., Daubert, C., & on behalf of the REVERSE study group (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq408 · Cited by 69
Redefining the Classifications of Response to Cardiac Resynchronization Therapy
Gold, M. R., Rickard, J., Daubert, J., Zimmerman, P., & Linde, C. M. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.11.010 · Cited by 79
Reduction of the Risk of Recurring Heart Failure Events With Cardiac Resynchronization Therapy
Goldenberg, I., Hall, W. J., Beck, C. A., Moss, A. J., Barsheshet, A., McNitt, S. A., Polonsky, S., Brown, M. W., & Zaręba, W. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.04.024 · Cited by 70
Blecker, S., Ladapo, J. A., Doran, K. M., Goldfeld, K. S., & Katz, S. D. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.08.002 · Cited by 69
Structure and function of coagulogen, a clottable protein in horseshoe crabs
Osaki, T., & Kawabata, S. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-3396-5 · Cited by 69
Defining the role of palliative care in older adults with heart failure
Bekelman, D. B., Hutt, E., Masoudi, F. A., Kutner, J. S., & Rumsfeld, J. S. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.10.005 · Cited by 76
“Despite optimal heart failure medication management, many patients continue to experience prototypical heart failure symptoms of breathlessness and fatigue [19,20].”
BackgroundCardiac myosin activation part 1: From concept to clinic
Malik, F. I., & Morgan, B. P. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.05.006 · Cited by 69
Metadata
- Authors
- Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., DeVries, D. W., & Feldman, A. M.
- Affiliations
- University of Colorado Health (US)
- University of Southern California (US)
- Penn State Milton S. Hershey Medical Center (US)
- Bryan Health (US)
- Johns Hopkins Hospital (US)
- Veterans Health Administration (US)
- Pfizer (United States) (US)
- University of Wisconsin–Madison (US)
- Thomas Jefferson University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-05-20
- Volume
- 350
- Issue
- 21
- Pages
- 2140-2150
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130907431
- Cited by
- 5,812
- References
- 22
- Citations by year
- 2026: 80 · 2025: 126 · 2024: 131 · 2023: 179 · 2022: 149 · 2021: 157 · 2020: 196 · 2019: 213 · 2018: 210 · 2017: 265 · 2016: 260 · 2015: 308 · 2014: 276 · 2013: 323 · 2012: 350
- FWCI
- 240.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
- Keywords
- cardiac resynchronization therapy, implantable cardioverter-defibrillator, advanced chronic heart failure, intraventricular conduction delay, heart failure hospitalization, mortality, cardiomyopathy, QRS duration, pharmacotherapy
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angiotensin-Converting Enzyme Inhibitors, Chronic Disease, Combined Modality Therapy, Diuretics, Female, Heart Failure, Hospitalization, Humans, Male, Pacemaker, Artificial, Risk, Spironolactone, Defibrillators, Implantable, Ventricular Dysfunction, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.